BioTrace Medical is Transforming Temporary Pacing

BioTrace Medical is a medtech company with an innovative product that eliminates complications and reduce costs in cardiac lead placement. The procedure cost to treat a cardiac perforation caused by cardiac lead placement can exceed $100,000. The Tempo Lead’s unique design virtually eliminates perforation risk, provides secure and stable temporary pacing, and allows patients to ambulate sooner after procedures such as TAVR.

EXIT TO MERIT MEDICAL SYSTEMS, INC. IN 2022 (NEWS HERE)